Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
23
pubmed:dateCreated
1990-1-19
pubmed:abstractText
Most developmentally regulated epitopes identified on embryonal carcinoma cells and murine preimplantation embryos are associated with a glycoprotein-bound large glycan called embryoglycan. To prepare monoclonal antibodies recognizing other, less immunogenic stage-specific embryonic epitopes, we used embryoglycan-negative embryonal carcinoma cells P19XT.1.1 as immunogen. One monoclonal antibody prepared by this strategy was found to react specifically with mouse embryonal carcinoma and embryo-derived stem cell lines. The target epitope, TEC-4, was found to be expressed on eggs and two-cell embryos but was undetectable on later stages of mouse embryos and adult mouse tissues. NaDodSO4/PAGE of immunoaffinity-isolated antigen revealed that TEC-4 epitope is associated with glycoproteins of apparent Mr 120,000 and 240,000. The epitope was resistant to oxidation by sodium periodate and to digestion by endoglycosidase F but was sensitive to treatment with protein-denaturing agents and proteases, which suggested that the epitope is located in the protein moiety of the molecule. In the course of retinoic acid-induced differentiation of embryonal carcinoma cells the epitope disappeared before the onset of morphological differentiation. The combined data indicate that TEC-4 is an unusual stage-specific embryonic antigen that may be amenable to direct genetic analysis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-2429884, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-2441394, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-2443254, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-2449911, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-2458292, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-2464500, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-2581941, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-281705, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-2860973, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-2918859, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-3277983, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-3283939, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-3477527, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-388439, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-4160044, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-4361679, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-558524, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-6183004, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-6535637, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-66184, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-6656766, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-6692975, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-6694356, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-6787139, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-6950406, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-6967725, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-7056443, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-7095898, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-7107698, http://linkedlifedata.com/resource/pubmed/commentcorrection/2574458-7264323
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
86
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
9337-41
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Unusual stage-specific embryonic antigen (TEC-4) defined by a monoclonal antibody to embryonal carcinoma cells defective in the expression of embryoglycan.
pubmed:affiliation
Department of Developmental Genetics, Czechoslovak Academy of Sciences, Prague.
pubmed:publicationType
Journal Article